Sechenov School
Home › Biochemistry › Allosteric Regulation of Enzymes

Allosteric Regulation of Enzymes

For medical students2 min readUpdated 2026-10-10

Allosteric regulation of enzymes is the process by which catalytic activity is modified through the non-covalent binding of specific regulatory molecules called effectors. Effector binding alters the spatial conformation of the enzyme, enabling the cell to instantly accelerate or inhibit metabolic pathways.

Binding MechanismEffectors bind to the enzyme non-covalently, making the regulation fully reversible.
Enzyme StructureThey have an oligomeric structure, consisting of multiple subunits (protomers).
LocalizationThey control initial, rate-limiting, or irreversible reactions within the cell.
Site PropertiesThey exhibit absolute or group specificity for their ligands.

Structure of Allosteric Enzymes

Allosteric enzymes possess a complex spatial organization. They are typically oligomeric proteins whose structure features two types of functional sites that are spatially separated from each other:

Often, these sites are located on different subunits. The regulatory protomer carries the allosteric site, while the catalytic protomer contains the active site. A single enzyme may have multiple allosteric sites: some specific for activators and others for inhibitors.

Mechanism of Action and Cooperativity

Allosteric regulation is fundamentally based on the property of cooperativity. The binding of an effector to the regulatory site induces a cooperative conformational change (spatial structure alteration) across all enzyme subunits. This leads to an alteration in the shape of the active site and the enzyme's affinity for the substrate.

Feedback Regulation

Allosteric enzymes are located at key control points in metabolic pathways: they catalyze initial, slowest steps or reactions at branch points of pathways. This is essential for controlling the entire cascade of transformations.

Most commonly in the body, regulation occurs via negative feedback (feedback inhibition). Its core principle is that when an end product accumulates in excess, it acts as an allosteric inhibitor for enzymes at the beginning of the chain. Concurrently, initial or intermediate substances can act as activators, accelerating substrate processing. This combination allows for extremely fine and rapid tuning of metabolic rates.

Regulation Example: Glucose Catabolism

A classic example of allosteric control is the glucose breakdown pathway, where ATP serves as the end product.

If ATP molecules are not consumed and accumulate, they signal an energy surplus. ATP acts as a negative feedback inhibitor, preventing excessive energy production when it is not required.

Target EnzymeRegulatorEffect
PhosphofructokinaseATP (end product)Inhibition
Pyruvate kinaseATP (end product)Inhibition
Pyruvate kinaseFructose-1,6-bisphosphate (intermediate metabolite)Activation

Conversely, the accumulation of the intermediate metabolite fructose-1,6-bisphosphate signals pyruvate kinase that there is an excess of substrate from the previous step, accelerating the conversion of phosphoenolpyruvate to pyruvate.

Mnemonic

Imagine an assembly line in a factory. If the finished goods warehouse is overflowing (accumulated end product), the automation system sends a signal to the very first machine (the allosteric enzyme of the initial stage) to halt the line and avoid wasting raw materials—this is negative feedback.

Frequently asked questions

Which allosteric enzymes regulate glycolysis?

Glycolysis is regulated by the following key allosteric enzymes: phosphofructokinase and pyruvate kinase.

These enzymes catalyze irreversible reactions of the metabolic pathway and respond to the cellular energy status:

  • Phosphofructokinase — inhibited by the end product ATP via negative feedback.
  • Pyruvate kinase — also inhibited by ATP, but additionally activated by an intermediate metabolite (fructose-1,6-bisphosphate) via a feed-forward mechanism.
What substances act as allosteric activators of phosphofructokinase?

Allosteric activators of phosphofructokinase include AMP, ADP, and fructose-2,6-bisphosphate.

These substances stimulate glycolysis depending on the cell's metabolic state:

  • AMP — activates phosphofructokinase during low energy status.
  • ADP — acts as an allosteric activator of phosphofructokinase-1 when the ATP/ADP ratio is low.
  • Fructose-2,6-bisphosphate — allosterically activates phosphofructokinase and stimulates glycolysis.
What is the difference between the allosteric site and the active site?

The active site binds the substrate and carries out the chemical reaction itself. The allosteric site binds the regulator (effector) and is spatially distant from the active site.

What is cooperativity?

This is a property of oligomeric enzymes where the binding of a molecule to one subunit induces a concerted change in the spatial configuration of all other subunits in the complex.

What kinds of reactions do allosteric enzymes catalyze?

They regulate key reactions: initial, irreversible, rate-limiting (slowest), or those located at branch points of metabolic pathways.

Go deeper

More topics in Biochemistry

AcetylcholinesterasePentose Phosphate Pathway (PPP)Creatine MetabolismEnzyme Activity RegulationPost-Translational ModificationsGlucose-Lactate Cycle (Cori Cycle)Carbohydrate Metabolism in ErythrocytesAtherosclerosisPhenylalanine and Tyrosine Metabolism DisordersEnzyme Phosphorylation and DephosphorylationPhospholipidsEnzyme Diagnostics: Principles and Clinical MarkersBiochemistry →